c-Src and cooperating partners in human cancer

被引：499

作者：

Ishizawar, R

Parsons, SJ

机构：

[1] Univ Virginia Hlth Syst, Ctr Canc, Charlottesville, VA 22908 USA

[2] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA

来源：

CANCER CELL | 2004年 / 6卷 / 03期

关键词：

D O I：

10.1016/j.ccr.2004.09.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The proto-oncogene c-src is rarely mutated in human cancers, and when overexpressed in normal cells is non- or weakly oncogenic. These observations have raised doubts about the involvement of c-src in the etiology of human tumors. However, recent studies have shown that c-Src, a non-receptor tyrosine kinase, exhibits elevated protein levels and activity in numerous types of human cancers. Furthermore, it has been found to be a critical component of multiple signaling pathways that regulate proliferation, survival, metastasis, and angiogenesis. Because of its important role in these oncogenic processes, it represents a therapeutic target ripe for exploitation.

引用

收藏

页码：209 / 214

页数：6

相关论文

共 63 条

[1] Src-dependent tyrosine phosphorylation regulates dynamin self-assembly and ligand-induced endocytosis of the epidermal growth factor receptor [J].

Ahn, S ;

Kim, J ;

Lucaveche, CL ;

Reedy, MC ;

Luttrell, LM ;

Lefkowitz, RJ ;

Daaka, Y .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (29) :26642-26651

[2] N7-Substituted-5-aryl-pyrrolo[2,3-d]pyrimidines Represent a Versatile Class of Potent Inhibitors of the Tyrosine Kinase c-Src [J].

Altmann, Eva ;

Widler, Leo ;

Missbach, Martin .

MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2002, 2 (03) :201-208

[3] Estradiol-binding mechanism and binding capacity of the human estrogen receptor is regulated by tyrosine phosphorylation [J].

Arnold, SF ;

Melamed, M ;

Vorojeikina, DP ;

Notides, AC ;

Sasson, S .

MOLECULAR ENDOCRINOLOGY, 1997, 11 (01) :48-53

[4] Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells [J].

Ballaré, C ;

Uhrig, M ;

Bechtold, T ;

Sancho, E ;

Di Domenico, M ;

Migliaccio, A ;

Auricchio, F ;

Beato, M .

MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (06) :1994-2008

[5] Src promotes destruction of c-Cbl: Implications for oncogenic synergy between Src and growth factor receptors [J].

Bao, J ;

Gur, G ;

Yarden, Y .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2438-2443

[6] Src family kinases and HER2 interactions in human breast cancer cell growth and survival [J].

Belsches-Jablonski, AP ;

Biscardi, JS ;

Peavy, DR ;

Tice, DA ;

Romney, DA ;

Parsons, SJ .

ONCOGENE, 2001, 20 (12) :1465-1475

[7] Tyrosine kinase signalling in breast cancer - Epidermal growth factor receptor and c-Src interactions in breast cancer [J].

Biscardi, JS ;

Ishizawar, RC ;

Silva, CM ;

Parsons, SJ .

BREAST CANCER RESEARCH, 2000, 2 (03) :203-210

[8] Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II [J].

Boerner, JL ;

Demory, ML ;

Silva, C ;

Parsons, SJ .

MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (16) :7059-7071

[9] Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases [J].

Boonyaratanakornkit, V ;

Scott, MP ;

Ribon, V ;

Sherman, L ;

Anderson, SM ;

Maller, JL ;

Miller, WT ;

Edwards, DP .

MOLECULAR CELL, 2001, 8 (02) :269-280

[10] Regulation, substrates and functions of src [J].

Brown, MT ;

Cooper, JA .

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3) :121-149

← 1 2 3 4 5 6 7 →